CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
enhanced with continuous glucose monitor (CGM) review to target diabetes distress in adults with type 1 diabetes. The efficacy of C...
New York, New York, United States and 2 other locations
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
New Brunswick, New Jersey, United States and 44 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
The Bronx, New York, United States and 18 other locations
Pregnant women aged 18-40 with gestational diabetes (GDM) will take part in this study. We want to see how two different insulin treatments ...
Phase 2, Phase 3
New York City, New York, United States and 4 other locations
evaluate the effect of a behavioral intervention on the number of preventive and treatment dental claims in a population of people with Type 2 Diabetes...
Phase 4
Long Island City, New York, United States
) found that consumption of 1 serving (cup) of milk/day was associated with \~30% lower risk of type 2 diabetes among LNP individuals, but n...
The Bronx, New York, United States
enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes...
The Bronx, New York, United States and 2 other locations
The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...
Phase 3
Laurelton, New York, United States and 51 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
New York, New York, United States and 96 other locations
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals ...
Phase 2, Phase 3
Hackensack, New Jersey, United States and 1 other location
Clinical trials
Research sites
Resources
Legal